UBS Group AG trimmed its position in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 9.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,064,016 shares of the company's stock after selling 106,290 shares during the period. UBS Group AG owned approximately 0.22% of Nutrien worth $65,671,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in NTR. Arrowstreet Capital Limited Partnership lifted its stake in Nutrien by 19.1% during the third quarter. Arrowstreet Capital Limited Partnership now owns 14,221,381 shares of the company's stock worth $834,962,000 after purchasing an additional 2,276,651 shares during the last quarter. TD Asset Management Inc lifted its holdings in shares of Nutrien by 16.5% in the third quarter. TD Asset Management Inc now owns 7,368,861 shares of the company's stock worth $432,838,000 after acquiring an additional 1,043,766 shares during the last quarter. Black Creek Investment Management Inc. lifted its holdings in shares of Nutrien by 57.3% in the third quarter. Black Creek Investment Management Inc. now owns 2,367,244 shares of the company's stock worth $139,050,000 after acquiring an additional 862,487 shares during the last quarter. Allianz Asset Management GmbH lifted its holdings in shares of Nutrien by 152.6% in the third quarter. Allianz Asset Management GmbH now owns 1,372,863 shares of the company's stock worth $80,662,000 after acquiring an additional 829,275 shares during the last quarter. Finally, Man Group plc lifted its holdings in shares of Nutrien by 5,178.4% in the third quarter. Man Group plc now owns 775,919 shares of the company's stock worth $45,577,000 after acquiring an additional 761,219 shares during the last quarter. 63.10% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
NTR has been the subject of a number of research reports. Canadian Imperial Bank of Commerce dropped their target price on shares of Nutrien from $90.00 to $88.00 and set an "outperformer" rating for the company in a report on Thursday, April 30th. UBS Group cut shares of Nutrien from a "neutral" rating to a "sell" rating and increased their target price for the stock from $63.00 to $67.00 in a report on Thursday, March 26th. Raymond James Financial increased their price target on Nutrien from $68.00 to $74.00 and gave the company a "market perform" rating in a research note on Friday, February 20th. Royal Bank Of Canada increased their price target on Nutrien from $80.00 to $85.00 and gave the company an "outperform" rating in a research note on Tuesday, April 7th. Finally, BNP Paribas Exane cut Nutrien from an "outperform" rating to a "neutral" rating in a research note on Monday, February 23rd. Eleven equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $80.00.
Get Our Latest Analysis on Nutrien
Nutrien Stock Up 0.7%
Shares of NYSE NTR opened at $75.78 on Tuesday. The company has a 50 day simple moving average of $74.85 and a 200 day simple moving average of $66.62. The firm has a market cap of $36.43 billion, a PE ratio of 16.26 and a beta of 0.64. Nutrien Ltd. has a 1 year low of $53.03 and a 1 year high of $85.36. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.34 and a quick ratio of 0.70.
Nutrien (NYSE:NTR - Get Free Report) last announced its earnings results on Wednesday, February 18th. The company reported $0.83 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.87 by ($0.04). The company had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.26 billion. Nutrien had a return on equity of 8.41% and a net margin of 8.43%.The firm's revenue for the quarter was up 5.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.31 earnings per share. On average, research analysts forecast that Nutrien Ltd. will post 5.12 EPS for the current year.
Nutrien Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, April 16th. Investors of record on Tuesday, March 31st were given a dividend of $0.55 per share. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $2.20 annualized dividend and a yield of 2.9%. This is an increase from Nutrien's previous quarterly dividend of $0.55. Nutrien's dividend payout ratio is 47.21%.
Nutrien Company Profile
(
Free Report)
Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.
Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.
Featured Stories
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.